Clinical Trial Update: Interrogating Biological Signaling Pathway Dysregulations and In Vitro Screening With Personalized Therapies in Relapsed or Refractory Mantle Cell Lymphoma, MCL MATCH Trial [NA]

View source ↗

Summary

This update notes the completion of the MCL MATCH trial, which investigates signaling pathway dysregulations and in vitro screening with personalized therapies …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma | NA | Status: COMPLETED